ABSTRACT
Globally orchestrated programs for the prevention of mother-to-child transmission (PMTCT) of HIV emerged in the late 1990s, when public health policy makers were at a loss over how to control the epidemic, and when providing universal access to AIDS therapies was not yet seen as a feasible option (Hardon 2012). This chapter focuses on the ways in which HIV testing has been pursued in these programs, and shows how procedures in some settings and historical moments only screened women for HIV, whereas in other settings, the tests were gateways to further clinical diagnoses and life-saving treatment.
